Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS2801203 A
Publication typeGrant
Publication dateJul 30, 1957
Filing dateMar 21, 1952
Priority dateMar 22, 1951
Publication numberUS 2801203 A, US 2801203A, US-A-2801203, US2801203 A, US2801203A
InventorsAnton Leb, Ernst Keintzel, Erwin Schauenstein, Eugen Muntean, Hans Lidl, Karl Bolz, Romuald Gager
Original AssigneeByk Gulden Lomberg Chem Fab
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Chi-ray method of digestive enzyme diagnosis using protected core of contrast agent
US 2801203 A
Abstract  available in
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

July 30, 1957 A. LEB ET AL 2,801,203

X-RAY METHOD OF DIGESTIVE ENZYME DIAGNQSIS USING PROTECTED CORE OF CONTRAST AGENT Filed March 21, 1952 MN s A a a mGr D m." D N AL "A W R G .l U l Nwfl K 00 L BMW R 7 E .ever been used nearly exclusively for some time. practical application these powdery substances are stirred United States Patent i X-RAY METHOD OF DIGESTIVE ENZYME DIAG- 11: USING PROTECTED. CORE: 0F CONTRAST Anton Leb, Hans Lidl, Romuald GagenEugen Muntean, Erwinv Schauenstein, Ernst Keintzel, and Karl 8012, Graz, Austria, assignors to Byk-Gulden Lomberg, Chemische Fabrik G. in. b. H., Konstanz, Germany Application March 21,1952, Serial No. 277,814

Claimspriority, application Germany March 22, 1951 4 Claims. (Cl. 167-95) Many different contrast agents and preparations for diagnostic. Xaray examination, which mostly diifer less intheirmanner ofuse. than in their chemical constitution, have already .been proposed. Especially for examinations. of the stomach and intestines insoluble contrast agentsin the form of powders, above all barium sulphate, sometimes also thorium oxide and/or mixtures in powder form containing these substances, have how- For with the addition of water to a thin paste which must be swallowed: by the patient. With the aid of this method it is possible to show stomach and intestines radiographically, to recognize ulcers, narrowings or dilations, and to observe the movement of these organs. It is however, impossible to observe in this manner the process of digestion itself or to draw any conclusions concerning the presence or absence of certain digestive enzymes.

It has however already been proposed to dispense X- ray contrast agents in the form of capsules and suchlike, especially in order to avoid complaints or irritations of the stomach by such substances which easily cause irritations, or by such substances which are changed by the acid of the stomach.

It has also already been proposed to prepare small quantities of barium sulphate for inclusion in tablets or pills containing pharmaceutically active substances. Their use was however only for the purpose of determining whether tablets or pills of a certain composition guaranteed a good decomposition in the stomach. They thus served as a guide for the pharmaceutical preparation of pills or tablets similarly prepared, which are however free of barium, as to whether good decomposition and thus the desired action is achieved in their therapeutic application.

On the other hand it is possible with the aid of the formed X-ray contrast preparations, according to the present invention, to draw conclusions based on the time of the beginning decomposition of their cores, as to the quantity of enzymes present, respectively absent or insufliciently present, which attack the basic foodstuffs, such as fats, proteins and carbohydrates, and furthermore, to draw conclusions in respect of disturbances of the glands which produce the enzymes.

According to the present invention new compositions of matter are prepared, i. e. formed substances which contain a powdery inorganic contrast agent which is insoluble in water and incapable of resorption and contains in the molecule at least one atom of high molecular weight, e. .g. difiicultly soluble salts of bismuth (siliceous bismuth), barium silicate and silver iodide, especially barium sulphate or thorium oxide, in a core together with at least one suitable binding agent. This core is coated with one basic foodstuff, i. e. a fat or a protein or a carbohydrate. It is the purpose of this coating to protect thecore extensively from decomposition in liquids which do not contain the specific enzyme, so that the 2,801,203 Patented July 30, 1957 ICC coredoes not decompose .or only decomposes. after great delay after theimmersion of the formed contrast agent in such liquids, whereas decomposition in the presence of corresponding enzymes occurs very much faster or may only then become possible. This means that an enzyme splitting fats will attack the new product, when coated with fat, an enzyme splitting proteins will attack the new product when coated with a protein and the same applies tothe carbohydrates. This new composition of matter may :be dyed by therapeuticallyharmless dye-stuffs. Only such basic foodstuffs are suitable which are insoluble in water or diflicultly soluble without digestion enzymes or which are rendered insoluble or diffic-ultly soluble withoutrsuch enzymes by suitable means. These conditions are met by .manyinsoluble fats. Protein bodies are used which are solubleper se, but are made insoluble by suitable treatments. The carbohydrates must be insoluble in water, or ditficultly soluble, and diflicultly hydrolysable but they must be split up by digestion enzymes.

The invention will now be described in detail, reference being made to the accompanying drawings, wherein Figures 1 to 4 represent cross-sections through pills or tablets; and

Figures 510 8 represent perspective views of different forms of preparations according to the invention.

The formed X-ray contrast preparations used, according to the present invention, have a suitable form, e. g. the form of pills, tablets as in Figure 5, lentils, as in Figure 7, beans, as in Figure 8, or peas, pearls as in Figure 6 and the like. The core A of Figures 1, 2 and 3 which contains the actual contrast agent can be prepared according to the usual processes with the application of suitable known binding agents which guarantee decomposition in aqueous media, as for example, starch, sugar, pectin, dextrin, gum arabic, starch-syrup and such-like. The process of the preparation corresponds to the methods already known. For example, a granulated substance can be prepared with the addition of starch, talcum powder and such-like, from the X-ray contrast agent, which is then pressed into tablets, preferably in the form of lozenges, on tablet presses.

Likewise a. pill-mass can be prepared, from which pills of suitable sizes are formed with the aid of pilling machines, from X-ray. contrast agents with the aid of sugar, sugar syrup and other suitable binding agents. Furthermore small cores A, of Figure 2, for example granulated material, crystallised sugar and such-like can be coated by a mixture of barium sulphate and sugar in a coating drum until these formed bodies A2 possess the desired s1ze. 4

A layer B of one of the basic foodstuifs in suitable thickness is added to this formed body which is easily decomposed by means of the binding agent in water and which represents thecore, and which contains the actual X-ray contrast agent insoluble in water. For examination for fat splitting enzymes this coating B consists of a solid fat which melts above 37 C. and which can be of vegetable, animal or synthetic origin. Fats which have been prepared by catalytic hydrogenation (hardening) of liquid vegetable or animal oils or such solid fats which are obtained from liquid fats by cooling and separation of the parts which have not solidified, can of course be used. Fats of a melting point of 43-48" C. have proved to be especially suitable. By way of example the following fats may be mentioned: beef-tallow, mutton-tallow, hardened peanut-oil, hardened cotton-seed oil, hardened palm-oil, hardened whale-oil, hardened rapeoil, distearate of propyleneglycol and glycerine esters of fatty acids with a carbon-chain between 16 and 20 carbon atoms, as obtained when. oxidizing parafiin.

.ly l40-l50 C. for about half an hour.

For examination for protein splitting enzymes this coating layer consists of a soluble protein which is made insoluble in water and which then at the utterrnost is only capable of swelling to a small degree (or not at all). For this purpose the core e. g. in the form of lentil is'either coated with a protein which becomes insoluble by drying or heating or by treatment with aldehydes e. g. with formaldehyde, glyoxal or with tanning agentse. g. tannin or by treatment with thrombin, if fibrinogen was used. As protein may be used c. g. egg-albumimserumalbumin and serum-globulin. Especially suitable for coating formed X-ray contrast preparations is muscle protein treatment but for which, however, heat after-treatment is favourable, or fibrinogen, which has been'after-treated with thrombin.

For examination for carbohydrate splitting enzymes,

. such carbohydrates or mixtures thereof which swell in water very slowly and become water soluble in the I presence of carbohydrate-splitting enzymes are of special .advantage as a coating layer. agar-agar. especially together with high molecular dextrin A coating which contains has proved itself to be especially suitable. Furthermore,

-'by way of example, the following starches may be men'- tioned: potato-, wheat-, rice-, rye-, buckwheat-, arrow- -.of beginning decomposition of the core. Thus the thickness of the layer when using fats of a melting point of 43 C. is best 0.5 mm., when using a fat of a melting point of 48 C. is best 0.2 mm. Generally the thickness of the layer can be between 0.1 and 1 mm.

As these coating agents often diffuse into the core to a'certain extent during the coating, it has proved advisable to use such X-ray contrast preparations which have the core isolated from the coating by an intermediate layer C of Figure 3. This intermediate layer C of Figure 3 must be at least easily decomposed in aqueous liquids, or even better must be easily soluble. Intermediate thin coating layers of sugar and/or pectin have proved best suited. Further suitable materials are milksugar, dextrose, fruit-sugar, mannite, water-soluble meth- I yl-cellulosc, gum arabic, polyvinylpyrrolidone.

In order to protect the coating layer consisting of the basic foodstuffs against the action of bacteria or the atmosphere it is convenient to use such X-ray contrast agents which possess above this foodstuff-layer a further suitv able, protective indifferent and easily soluble layer D as in Figure 4 as for example, a layer of sugar. This layer of sugar can be aromatized and can also be dyed by means of a harmless dyestulf in order to characterize the kind of X-ray contrast agent concerned. Instead of sugar e. g. milk-sugar, dextrose, fruit-sugar, pectin, starch-sugar may be used. The whole preparation or at least the final outside layer may be dyed.

The layer of the basic foodstuff, such as fat, protein or carbohydrate, can also contain conserving agents (e. g. esters of p-hydroxy-benzoic acid, benzoic and salicylic acid) for better stability, and in case there is no final coating layer, can also contain harmless dyestuffs for characterization. Furthermore they can also contain admixtures which are not detrimental to the desired action of. the layer. Thus for example a layer of fat can contain lecithin and such-like.

The coating layer of basic foodstuff is applied to the formed bodies whose preparation has already previously been described and which may be coated with an easily I (actomyocin) which does not necessarily require aftersoluble layer such as a layer of sugar, in a manner known already in that the basic foodstuffs in a liquid form, i. e., usually in dissolved form or liquified, is coated on according to any suitable process as evenly as possible. Liquid form means in a liquid state, in solution or suspension.

This process can be carried out by dipping the formed bodies into a suitable solution of the required basic foodstuff and evaporation of the solvent hereafter. In case an insufficient thickness is obtained after dipping once, the process can be repeated. The coating of the required layer in a coating drum has proved especially suitable whereby it is especially advantageous to remove the solvent by means of a current of air which can be cold or hot and which is blown into the drum, if solutions are used in the coating process. Furthermore it has proved advantageous to add the coating agent by means of a spray gun as used in the lacquer technique, as then the applied layer is freed almost instantaneously from the solvent and adhesion of the single forming bodies is avoided. A layer of fat is advantageously applied by means of a solution of fat in an organic solvent,

but carbohydrates and proteins are advantageously applied in aqueous solution. Furthermore the application of fats can also be carried out by spraying a liquid, that means a molten fat upon the formed bodies. In this case air need not be blown into the coating drum. On the other hand it is advantageous to cool the coating drum in this case. Also pulverized (powdered) fat may be used advantageously. It is to be recommended when using fibrinogen solution as coating agent to spray alternately the said solution and a solution of thrombin. The after-treatment of the coated formed bodies, for example, by heat or with formalin, can be carried out in the coating drum itself, or also otherwise. It is mostly expedient, especially when using aqueous solutions, to blow an air current warmed to -50 C. into the coating drum, whereby the water is removed faster and also a certain after-treatment is then already achieved. A fur- .ther especially advantageous kind of applying consists therein that two components (identical or different ones) of the same group (two fats, two proteins or two carin powdered form. coating drum and the two components may be supplied bohydrates) are applied simultaneously one in the liquid form (liquified, in solution or in suspension) the other This process is carried out in a either separately or together or the powdered component suspended in the liquid component. When coating with protein on the one hand e. g. finely powdered protein is used which maybe already insoluble and on the other hand a solution ofprotein e. g. a solution of actomyocin.

When producing coatings of carbohydrates e. g. a mixture of finely powdered agar-agar and a solution of dextrirr or finely powdered starch and a solution of agaragar or tragacanth may be used. In the case of fats,

, e. g. a hardened fat and mutton fat, in the case of proteins, casein and actornyocin can be used. The advantage of this method is that the coatings may be prepared tion of the digestive organs with simultaneous use of X-ray contrast preparations containing the three different basic foodstuffs, it is advantageous to choose a different outside appearance e. g. outer form for each of the three can be made in a differentiating size.

different X-ray contrast preparations, for example, a lentil, pea, and bean form. From similar considerations the three differently formed X-ray contrast preparations The same formed X-ray contrast preparations with a different thickness of layers may be characterized by a different form or size and/or colour. The following examples serve to illustrate the invention without limiting it in any way.

Example 1 Several highly curved lozenges containing within their core 83% of barium sulphate which are coated with a layer 0.45 mm. thick consisting of beef fat of melting point 43 C. and treated with a conserving agent and keratin, are swallowed with a little water. The X-ray picture obtained from a person under examination who has a normal fat digestion, i. e., who possesses the normal amount of fat splitting enzymes, shows up to about 3 hours after swallowing black, round or oval discs, according to their internal position (the images of the lozenges), after which time the lozenges begin to dissolve. A dark, fogg'ed shadow which continues to increase in density begins to spread out from the lozenges which assume uneven shapes, become smaller, disintegrate into single particles and finally vanish altogether. Persons suffering from defective fat digestion require a time of 4, 6, 8 or more hours in order to decompose the lozenges, or do not decompose the lozenges at all.

Example 2 Pills containing barium sulphate which are evenly coated with a layer 3 mm. thick of laminated fibrin and also possess a dyed sugar layer, are used. Persons possessing a normal protein digestion will already exhibit after about 170 minutes similar phenomena to those described in Example 1, which can be observed and photographed.

Example 3 Lozenges which contain within their core barium sulphate and which are coated with a layer consisting of agar-agar, high molecular dextrine and pasty starch, and which have been after-treated by formalin vapours and by the efiects of heat, and which possess a protective layer consisting of sugar, are used. With persons under examination who have a normal carbohydrate digestion, the lozenges begin to decompose after about 2% hours.

Example 4 A pill mass, from which 1000 pills are formed with the use of a mixture of equal parts of starch and barium sulphate as scattering agent, is prepared from 250 g. of barium sulphate, 75 g. of powder sugar and 25 g. of wheat starch with the aid of sugar syrup. After drying the pills in warm air, they are immersed in beef fat which has been warmed to just above its melting point, and which contains 1% of keratin concentrate and 0.5% of a mixture of the methyl and propyl esters of p-hydroxybenzoic acid. After leaving the pills in the fat for a short time they are taken out with the aid of a sieve and placed into a cooled coating drum. Powdery beef fat dyed with keratin concentrate and conserved with p-hydroxybenzoic acid ester is then added in the coating drum. The coated pills obtained possess a smooth yellowish surface. The thickness of the fatty layer amounts to 0.4 mm.

Example5 Lentil-like tablets weighing 0.125 g. are prepared in the usual manner from 2 kg. of barium sulphate, 380 g. of wheat starch, 100 g. of talcum, g. of magnesium stearate and g. of gelatin. The cores are placed into a coating drum and coated by the addition of molten fat with a melting point of 48 C. which has been prepared from vegetable oil by hydrogenation and which is sprayed onto the cores contained in the rotating and slightly cooled coating drum by means of a spray gun until a coating layer of 0.3 mm. has been obtained. The cores thus obtained are then coated in a second coating drum with a sugar layer which has been dyed red.

6 Example 6 Lentil-like cores similar to those described in Example 5 are then coated with a layer approximately 0.1 mm. thick consisting of sugar and agar-agar. A layer consisting of a concentrated solution of mutton tallow in ethyl acetate 0.4 mm. thick, is subsequently sprayed on with simultaneous blowing in of air into the coating drum. Finally the tablets are again coated with a sugar layer.

Example 7 Uncoated pills prepared according to Example 4 are repeatedly dipped into a solution of fibrinogen. After each immersion the pill is briefly dipped into distilled water which contains a little thrombin and dried. This process is repeated until a layer of about 0.2 mm. thickness has been formed. The pills thus coated are finally well dried and after-treated in a coating drum with a mixture of talcum and a brown, insoluble dyestutf.

Example 8 Uncoated lentil-like tablets prepared according to Example 5 are placed in a coating drum. A 1.5% solution of actomyocin is sprayed onto the lozenges by means of a spray gun with such a velocity that the lozenges do not stick together. A stream of warm air is simultaneously blown into the coating drum. After a layer of 0.45 mm. thickness has been obtained the coated lozenges are after-treated in a drying cupboard at 60 C. Finally, they are coated in a further coating drum with a sugar layer dyed green.

Example 9 Uncoated lentil-like tablets prepared according to Example 5 are placed in a coating drum. With simultaneous blowing in of warm air into the coating drum a solution of agar-agar and dextrine, which also contains a little lactose and a trace of glycerine, is sprayed onto the tablets. After a layer of 0.3 mm. thickness has been obtained they are dried at 60 C. in a drying cupboard and finally a sugar layer dyed orange is added in a further coating drum.

What we claim is:

l. The method of diagnosing malfunctioning of the digestive process in humans by testing for the presence and activity of a human digestive ferment in vivo which comprises orally administering a diagnostic agent comprising a core of a water-insoluble X-ray contrast agent, incapable of resorption, said core being coated with a continuous layer of water-insoluble, non-water-swelling foodstuff specifically digestible by said ferment, and measuring the time of disintegration of said foodstuff layer in the human alimentary tract by X-ray observation.

2. The method set forth in claim 1 wherein said foodstuff layer comprises a fat and said digestive ferment tested is a fat-splitting ferment.

3. The method set forth in claim 1 wherein said foodstuff layer comprises a carbohydrate and said digestive ferment tested is a carbohydrate-splitting ferment.

4. The method set forth in claim 1 wherein said foodstulf layer comprises a protein and said ferment tested is a protein-splitting ferment.

by Worton et al.,

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US1815902 *Jul 16, 1927Jul 28, 1931Nat Aniline & Chem Co IncDevice for administering medicaments
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3017329 *Aug 15, 1957Jan 16, 1962Dow Chemical CoMethod of locating enteric constrictions with a plurality of pills containing an x-ray contrast agent
US3131123 *Jan 12, 1960Apr 28, 1964Lab Francais De TherapeutiqueEnteric tablets and manufacture thereof
US3146169 *Jun 8, 1962Aug 25, 1964Burroughs Wellcome CoPharmaceutical formulations and their manufacture
US3181998 *Aug 12, 1960May 4, 1965Kanig Joseph LTablet disintegration
US3493652 *Sep 14, 1962Feb 3, 1970Hartman Charles WControlled release medicament
US3917812 *Mar 6, 1974Nov 4, 1975Boehringer Mannheim GmbhCompositions and method for diagnosing diseases of the pancreas
US4002731 *Jun 17, 1974Jan 11, 1977Sterling Drug Inc.Diagnostic process using sodium tyropanoate
US4193985 *Mar 23, 1978Mar 18, 1980A/S Alfred BenzonMultiple-units drug dose
US4339463 *Jul 16, 1980Jul 13, 1982Shionogi & Co., Ltd.Enterosoluble hard-capsulated medicaments
US4397835 *Apr 28, 1982Aug 9, 1983Shionogi & Co., Ltd.Enterosoluble hard-capsulated medicaments
US4693886 *Apr 22, 1985Sep 15, 1987Alza CorporationOsmotic device with inert core
US4900557 *Dec 19, 1988Feb 13, 1990Troponwerke Gmbh & Co. KgPellet formulation
US5958450 *Dec 5, 1995Sep 28, 1999Phillip Peatey & Gunter PauliMethod of drug delivery and coated oral dosage forms for use in the method
US7276252 *May 18, 2001Oct 2, 2007Massachusetts Institute Of TechnologyMethod and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
US7875290Oct 7, 2005Jan 25, 2011Massachusetts Institute Of TechnologyMethod and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
US20020015728 *May 18, 2001Feb 7, 2002Payumo Francis C.Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
US20060110443 *Oct 7, 2005May 25, 2006Massachusetts Institute Of TechnologyMethod and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form
WO2004098649A2 *May 4, 2004Nov 18, 2004Philips Intellectual Property & Standards GmbhApparatus and method for examining an object by means of elastically scattered x-ray radiation and contrast agent
WO2004098649A3 *May 4, 2004Jan 13, 2005Philips Intellectual PropertyApparatus and method for examining an object by means of elastically scattered x-ray radiation and contrast agent
U.S. Classification424/9.411, 424/472, 424/439, 424/479
International ClassificationA61K49/04
Cooperative ClassificationA61K49/0409
European ClassificationA61K49/04F